[1] Ono F,Yasumoto S.Genital candidiasis[J].Nippon Rinsho,2009,67(1):157-161. [2] pappas PG,Kauffman CA,Andes D.Clinical practice guidelines for the management of candidiasis:2009 update by the infectious diseases society of America[J].Clin Infect Dis,2009,48(5):503-535. [3] National Committee for Clinical laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeasts[S].Approved standard M27-A.1997. [4] 宫毓静,安汝国,虞慧,等.164种中药乙醇提取物抗真菌作用研究[J].中草药,2002,33(1):42-47. [5] 闻平,陈蕾,俞晓丽,等.胡桃揪提取物抗白念珠菌作用的机制研究[J].中药药理与临床,2008,24(1):51-53. [6] Seneviratne CJ,Wong RW,Samaranayake LP.Potent anti-microbial activity of traditional Chinese medicine herbs against Candida species[J].Mycoses,2008,51(1):30-34. [7] Keith I.Immune system effects of echinacea,ginseng,and astragalus:a review[J].Integrative Cancer Therapies,2003,2(3):247-267. [8] Chapagain,Wiesman.In vitro study of the antifungal activity of saponin-rich extracts against prevalent phytopathogenic fungi[J].Industrial crops and products,2007,26(2):109-115. [9] Sojakova M,Liiyrajoya D,Messer SA,et al.Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia[J].Mycopathologia,2004,157(2):163-169. [10] Perea S,Patterson TF.Antifungal resistance in pathogenic fungi[J].Clin Infect Dis,2002,35(9):1073-1080. [11] Muller FM,Staudigel A,Salvenmoser S,et al.Cross-resistalce to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes[J].Antimicrob Agents Chemother,2007,57(4):3014-3016 [12] Sabatellis F,Patel R,Sobel JD,et al.In vitro activities of posaconzole,fluconazole,itraconazole,voriconazole and amphotericin B against a large collection of clinically important molds and yeasts[J].Antimicrob Agents Chemother,2006,50(6):2009-015. |